U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Frederick, MD — Gov. Wes Moore on Friday announced that AstraZeneca will invest $2 billion to expand its operations in Maryland in what he described as the “single largest private investment in ...

This is read by an automated voice. Please report any issues or inconsistencies here. AstraZeneca becomes second major pharmaceutical company to agree to lower Medicaid drug prices under Trump ...

AstraZeneca will build a $4.5 billion manufacturing facility in Albemarle County, Virginia. The new plant is expected to create approximately 3,600 jobs in the region. The facility will produce drugs ...

AstraZeneca has signed a $555 million deal with San Francisco biotech Algen Biotechnologies that will tap the latter company’s artificial intelligence platform to boost discovery of new targets in ...

AstraZeneca shares rallied on Wednesday after the U.K.-based pharmaceuticals giant and its Japanese partner said the Food and Drug Administration was reviewing one of its drugs to treat breast cancer.

AstraZeneca has asked the Supreme Court to hear its case challenging the Medicare Drug Price Negotiation Program created through the Inflation Reduction Act (IRA). According to the Supreme Court’s ...

AstraZeneca in January also stopped its $610 million plans to construct a vaccine R&D and manufacturing site in the U.K. AstraZeneca has put on ice its £200 million (roughly $271 million) investment ...

Pharmaceutical companies AstraZeneca and Eli Lilly & Co. are planning to locate major manufacturing facilities in Albemarle and Goochland counties respectively, a state official has confirmed. Last ...

AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...